- $58.35bn
- $57.34bn
- $2.31bn
Natera Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Natera Q4 Net Income USD -53.8 Million
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems
U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal
Natera falls as $96 mln patent verdict overturned
CareDx gets $96 million jury win for Natera overturned
Guardant Health sues rival Natera over cancer-testing trade secrets (updated)
Guardant Health sues Natera alleging trade secrets theft; shares of companies fall
Guardant Health sues rival Natera over cancer-testing trade secrets
Barclays starts coverage on Natera with 'outperform' rating
Brief: Natera Inc Says Co Expects Total Revenues Of Approximately $1.7 Bln In Full Year 2024
Brief: Natera Announces Enrollment Of First Patients In Sagittarius: A Randomized, Phase III Clinical Trial In Colon Cancer
Brief: Natera Announces Medicare Coverage For Prospera In Single Lung Transplant Recipients
Founder And Executive Chairman Matthew Rabinowitz Named 2024 Research And Development Leader Of The Year
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Natera rises on annual revenue forecast raise, PT hikes
Natera Inc reports results for the quarter - Earnings Summary